We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+5.81%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$32.7B
AUM Growth
+$3.39B
(+12%)
Cap. Flow
+$2.02B
Cap. Flow
% of AUM
6.18%
Top 10 Holdings %
Top 10 Hldgs %
20.34%
Holding
1,273
New
114
Increased
570
Reduced
394
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$437M |
| 2 |
Intuit
INTU
|
+$333M |
| 3 |
Mastercard
MA
|
+$203M |
| 4 |
Booking.com
BKNG
|
+$186M |
| 5 |
Alibaba
BABA
|
+$155M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$290M |
| 2 |
Akamai
AKAM
|
+$278M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$264M |
| 4 |
Cognizant
CTSH
|
+$252M |
| 5 |
Acuity Brands
AYI
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.14% |
| 2 | Financials | 16.99% |
| 3 | Healthcare | 14.67% |
| 4 | Consumer Discretionary | 12.2% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
AB InBev
BUD
$155B
| $1.17M | ﹤0.01% |
10,623
+466
| +5% | +$53.4K |
|
652
Genuine Parts
GPC
$16.6B
| $1.17M | ﹤0.01% |
12,634
-369
| -3% | -$33.9K |
|
653
JD.com
JD
$40.6B
| $1.17M | ﹤0.01% |
29,804
-5,574
| -16% | -$210K |
|
|
AIG.WS
654
DELISTED
American International Group, Inc.
AIG.WS
| $1.16M | ﹤0.01% |
54,933
+26,006
| +90% | +$539K |
|
655
American Water Works
AWK
$26.2B
| $1.15M | ﹤0.01% |
14,802
+21
| +0.1% | +$1.65K |
|
|
XBKS
656
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
| $1.15M | ﹤0.01% |
37,065
+2,932
| +9% | +$83.7K |
|
657
EQT Corp
EQT
$33.4B
| $1.15M | ﹤0.01% |
36,058
+257
| +0.7% | +$8.14K |
|
658
Texas Pacific Land
TPL
$29.4B
| $1.13M | ﹤0.01% |
34,677
-3,456
| -9% | -$112K |
|
659
Invesco Water Resources ETF
PHO
$1.94B
| $1.13M | ﹤0.01% |
41,926
-1,772
| -4% | -$47.2K |
|
660
Cooper Companies
COO
$13.7B
| $1.13M | ﹤0.01% |
18,808
+6,256
| +50% | +$340K |
|
|
WRK
661
DELISTED
WestRock Company
WRK
| $1.12M | ﹤0.01% |
19,831
+51
| +0.3% | +$2.77K |
|
|
IPHS
662
DELISTED
Innophos Holdings, Inc.
IPHS
| $1.12M | ﹤0.01% |
25,536
+18,536
| +265% | +$832K |
|
|
OA
663
DELISTED
Orbital ATK, Inc.
OA
| $1.1M | ﹤0.01% |
11,199
+4,163
| +59% | +$411K |
|
|
ELLI
664
DELISTED
Ellie Mae Inc
ELLI
| $1.09M | ﹤0.01% |
9,912
+514
| +5% | +$55.6K |
|
665
Golar LNG
GLNG
$5.07B
| $1.08M | ﹤0.01% |
48,370
+2,060
| +4% | +$51.7K |
|
|
TESS
666
DELISTED
Tessco Technologies Inc
TESS
| $1.07M | ﹤0.01% |
80,857
+1,687
| +2% | +$23.7K |
|
667
Celanese
CE
$5.19B
| $1.07M | ﹤0.01% |
11,253
+112
| +1% | +$9.98K |
|
|
SPN
668
DELISTED
Superior Energy Services, Inc.
SPN
| $1.07M | ﹤0.01% |
10,245
+164
| +2% | +$19.1K |
|
669
Johnson Controls International
JCI
$87.4B
| $1.06M | ﹤0.01% |
24,523
-383
| -2% | -$16K |
|
670
Sanofi
SNY
$104B
| $1.06M | ﹤0.01% |
22,065
+1,286
| +6% | +$61.5K |
|
671
Unilever
UL
$130B
| $1.04M | ﹤0.01% |
17,172
-212
| -1% | -$12.6K |
|
672
York Water
YORW
$503M
| $1.04M | ﹤0.01% |
30,000
| – | – |
|
|
CERN
673
DELISTED
Cerner Corp
CERN
| $1.04M | ﹤0.01% |
15,718
-378
| -2% | -$24.2K |
|
|
STMP
674
DELISTED
Stamps.com, Inc.
STMP
| $1.04M | ﹤0.01% |
6,741
-552
| -8% | -$69.5K |
|
675
Ligand Pharmaceuticals
LGND
$6.06B
| $1.04M | ﹤0.01% |
13,779
+1,891
| +16% | +$132K |
|
Similar funds
QCM
Brown Advisory's Q2 2017 Portfolio in Review
As of Q2 2017, Brown Advisory held 1,273 positions worth $32.7B, up 12% from $29.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Brown Advisory deployed $2.02B of net new capital in Q2 2017, opening 114 new positions and adding to 570 existing holdings. Its largest new stake was Altaba Inc: 2,311,186 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $290M trimmed.
- Brown Advisory's largest Q2 2017 buy was Altaba Inc: 2,311,186 shares worth $126M.
- Brown Advisory added most to Zoetis in Q2 2017, an estimated $437M increase.
- Brown Advisory's biggest Q2 2017 reduction was Alexion Pharmaceuticals, cutting an estimated $290M.
- Brown Advisory fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $264M.
- Brown Advisory's ten largest holdings make up 20% of its $32.7B portfolio in Q2 2017.
- Brown Advisory opened 114 new positions and closed 56 in Q2 2017.
- Brown Advisory's portfolio value rose 12% quarter-over-quarter to $32.7B.
Based on Brown Advisory's 13F filing for Q2 2017, filed 14 Aug 2017.